Group 1 - The acquisition report by Huatai United Securities for Shangwei Co., Ltd. indicates that the acquisition is based on the recognition of the long-term investment value and development prospects of the listed company [6][9] - The financial advisor confirms that the acquisition report complies with relevant laws and regulations, and no false records or misleading statements were found [16][27] - The acquirer, Fuhua Chemical, has a registered capital of 82,705 million RMB and operates in the chemical industry, focusing on pesticide production and chemical sales [7][9] Group 2 - Fuhua Chemical's financial data shows total assets of 1,344,052.07 million RMB and net assets of 372,473.69 million RMB as of December 31, 2024, with a debt-to-asset ratio of 69.32% [9] - The company reported operating income of 767,189.24 million RMB and a net profit of 60,271.22 million RMB for the year 2024 [9] - The acquirer has committed to maintaining the independence of the listed company and avoiding any conflicts of interest or related party transactions that could harm the company's interests [19][21][23] Group 3 - The acquisition does not involve changes in the actual controller of the listed company, ensuring that the company's operational independence remains intact [19][26] - Fuhua Chemical has outlined plans for potential asset restructuring and business adjustments within the next 12 months, while ensuring compliance with legal requirements [16][18] - The financial advisor has verified that the acquisition funding will come from the acquirer's own or legally raised funds, ensuring the legality of the funding sources [13][14]

Group 1 - The core opinion of the article is that Fuhua Chemical intends to acquire shares of Shangwei Co., Ltd. through a cash subscription, aiming to enhance control and decision-making capabilities over the company [1][9][10] - Fuhua Chemical's basic information includes a registered capital of 82.705 million yuan and a business scope that encompasses pesticide production, chemical products sales, and technology services [2][3] - The shareholding structure indicates that Fuhua Group controls 56.32% of Fuhua Chemical, making it the controlling shareholder [3][4] Group 2 - The acquisition aims to recognize the long-term investment value of Shangwei Co., Ltd. and maintain strategic stability [9][10] - The acquisition process has been approved by the boards of both Fuhua Chemical and Shangwei Co., Ltd., with necessary legal procedures underway [10][12] - The subscription agreement stipulates a maximum of 181,338,685 shares to be acquired at a price of 6.31 yuan per share, which will increase Fuhua Chemical's stake to 42.21% post-acquisition [10][11][13] Group 3 - Fuhua Chemical has committed to not transferring the newly acquired shares for 36 months following the issuance [10][11] - The funding for the acquisition will come entirely from Fuhua Chemical's own funds or legally raised funds, ensuring compliance with relevant regulations [16] - There are no existing legal restrictions on the shares held by Fuhua Chemical, and the company has not faced any significant legal penalties in the past five years [6][14][15]

北京天驰君泰（成都）律师事务所 关于 福华通达化学股份公司免于发出要约事宜 之 法律意见书 法律意见书 北京天驰君泰（成都）律师事务所 法律意见书 北京天驰君泰（成都）律师事务所 关于福华通达化学股份公司免于发出要约事宜之 致：福华通达化学股份公司 根据福华通达化学股份公司（以下简称"福华化学"或"收购人"）的委托， 北京天驰君泰（成都）律师事务所（以下简称"本所"）现就福华通达化学股份 公司免于发出要约事宜，依据《中华人民共和国证券法》《中华人民共和国公司 法》 《上市公司收购管理办法》 《律师事务所从事证券法律业务管理办法》和《律 师事务所证券法律业务执业规则（试行）》等有关法律、行政法规、部门规章的 相关规定，按照律师行业公认的业务标准、道德规范和勤勉尽责精神出具本法律 意见书。 为出具本法律意见书，本所及本所律师特作如下声明： 出具本法律意见书之目的，不包括中国香港特别行政区、中国澳门特别行政区及 中国台湾地区）现行有效的法律、法规及其他规范性文件的规定发表法律意见， 并仅根据对相关事实的了解和对法律的理解发表法律意见。 提供了本所为出具本法律意见书所要求收购人提供的原始书面材料、副本材料、 复印材料 ...

尚纬股份有限公司 收购报告书 | 上市公司： | 尚纬股份有限公司 | | --- | --- | | 上市地点： | 上海证券交易所 | | 股票简称： | 尚纬股份 | | 股票代码： | 603333.SH | | 收购人： | 福华通达化学股份公司 | | --- | --- | | 住所/通讯地址： | 四川省乐山市五通桥区金粟镇 | 签署日期：二〇二五年七月 尚纬股份有限公司 收购报告书 声 明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 一、本报告书系收购人依据《中华人民共和国公司法》《中华人民共和国证 券法》《上市公司收购管理办法》《公开发行证券的公司信息披露内容与格式准 则第 16 号——上市公司收购报告书》及相关的法律、法规编写本报告书。 二、依据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司 收购管理办法》《公开发行证券的公司信息披露内容与格式准则第 16 号——上 市公司收购报告书》的规定，本报告书已全面披露收购人在尚纬股份拥有权益的 股份。 三、截至本报告书签署日，除本报告书披露的持股信息外，收购人没有通过 任何其他方式在尚纬股份拥有权益。 四、收 ...

北京天驰君泰（成都）律师事务所 关于 福华通达化学股份公司免于发出要约事宜 之 法律意见书 1 北京天驰君泰（成都）律师事务所 法律意见书 北京天驰君泰（成都）律师事务所 关于福华通达化学股份公司免于发出要约事宜之 法律意见书 致：福华通达化学股份公司 根据福华通达化学股份公司（以下简称"福华化学"或"收购人"）的委托， 北京天驰君泰（成都）律师事务所（以下简称"本所"）现就福华通达化学股份 公司免于发出要约事宜，依据《中华人民共和国证券法》《中华人民共和国公司 法》《上市公司收购管理办法》《律师事务所从事证券法律业务管理办法》和《律 师事务所证券法律业务执业规则（试行）》等有关法律、行政法规、部门规章的 相关规定，按照律师行业公认的业务标准、道德规范和勤勉尽责精神出具本法律 意见书。 为出具本法律意见书，本所及本所律师特作如下声明： 1.本所律师依据本法律意见书出具之日前已发生或存在的事实和我国（仅为 出具本法律意见书之目的，不包括中国香港特别行政区、中国澳门特别行政区及 中国台湾地区）现行有效的法律、法规及其他规范性文件的规定发表法律意见， 并仅根据对相关事实的了解和对法律的理解发表法律意见。 2.福华化 ...

北京天驰君泰（成都）律师事务所 关于 《尚纬股份有限公司收购报告书》 之 法律意见书 1 北京天驰君泰（成都）律师事务所 法律意见书 北京天驰君泰（成都）律师事务所 为出具本法律意见书，本所及本所律师特作如下声明： 1.本所律师依据本法律意见书出具日前已发生或存在的事实和我国（仅为出 具本法律意见书之目的，不包括中国香港特别行政区、中国澳门特别行政区及中 国台湾地区）现行有效的法律、法规及其他规范性文件的规定发表法律意见，并 仅根据对相关事实的了解和对法律的理解发表法律意见。 2.福华化学保证，其已向本所披露一切足以影响本法律意见书出具的事实并 提供了本所为出具本法律意见书所要求收购人提供的原始书面材料、副本材料、 复印材料、承诺函或证明，并无隐瞒记载、虚假陈述和重大遗漏之处；收购人提 供给本所的文件和材料是真实、准确、完整和有效的，并无隐瞒、虚假和重大遗 漏之处，且文件材料为副本或复印件的，其与原件一致和相符。 3.对于本法律意见书至关重要而又无法得到独立的证据支持的事实，经办律 师依赖有关政府部门、福华化学和其他有关单位出具的证明文件出具本法律意见 书。 2 北京天驰君泰（成都）律师事务所 法律意见书 关 ...

华泰联合证券有限责任公司 关于 尚纬股份有限公司 收购报告书 之 财务顾问报告 财务顾问 二〇二五年七月 财务顾问声明 根据《中华人民共和国公司法》、《中华人民共和国证券法》、《上市公司 收购管理办法》及《公开发行证券的公司信息披露内容与格式准则第 16 号—— 上市公司收购报告书》等法律法规和规范性文件的规定，华泰联合证券有限责任 公司（以下简称"本财务顾问"）按照行业公认的业务标准、道德规范，本着诚 实信用、勤勉尽责的精神，对本次收购的相关情况和资料进行了核查，对收购人 出具的《尚纬股份有限公司收购报告书》所披露的内容出具财务顾问报告。 为此，本财务顾问特作出以下声明： 1、本财务顾问依据的有关资料由收购人提供。收购人已作出承诺，保证其 所提供的资料均为真实、准确、完整的原始书面资料或副本资料，副本资料或复 印件与其原始资料或原件一致，所有文件的签名、印章均是真实的；所有文件和 材料不存在虚假记载、误导性陈述或重大遗漏，并对所提供信息的真实性、准确 性和完整性承担法律责任。 2、本财务顾问已履行勤勉尽责义务，对收购报告书的内容进行了核查和验 证，未发现虚假记载、误导性陈述或者重大遗漏，并对此承担相应的责任 ...

通过天眼查大数据分析，尚纬股份有限公司共对外投资了9家企业，参与招投标项目2305次，知识产权 方面有商标信息53条，专利信息202条，此外企业还拥有行政许可85个。 来源：金融界 尚纬股份最新一期业绩显示，截至2025一季报，公司营业总收入2.42亿元、同比减少4.15%，归属净利 润1449.43万元，同比增长12.25%，扣非净利润1742.14万元，同比减少1.87%，流动比率2.552、速动比 率2.230、资产负债率31.06%。 天眼查商业履历信息显示，尚纬股份有限公司，成立于2003年，位于乐山市，是一家以从事电气机械和 器材制造业为主的企业。企业注册资本62152.7586万人民币，实缴资本62152.7586万人民币。公司法定 代表人为叶洪林。 金融界消息 截至2025年7月30日收盘，尚纬股份（603333）报收于8.18元，上涨2.63%，换手率3.59%， 成交量22.30万手，成交金额1.81亿元。 资金流向方面，今日主力资金净流入1842.22万元，占比成交额10.19%。其中，超大单净流入489.38万 元、占成交额2.71%，大单净流入1352.84万元、占成交额7.49%， ...

Group 1 - The company plans to issue A-shares to its controlling shareholder, Fuhua Chemical, at a price of 6.31 yuan per share, raising up to 1.144 billion yuan, primarily to supplement working capital [1] - The issuance price represents an approximately 30% discount compared to the closing price of 8.16 yuan per share on July 17, raising market concerns about the impact on minority shareholders [1][2] - Following the issuance, Fuhua Chemical's stake in the company will increase from 25.35% to 42.21%, further consolidating its control [2] Group 2 - The wire and cable industry, where the company operates, is facing intense competition and low market concentration, with large enterprises dominating due to scale and brand influence [2] - The company is experiencing a significant decline in revenue, with projected 2024 revenue of 1.735 billion yuan, a year-on-year decrease of 21.39%, and a net profit of 16.34 million yuan, down 20.06% [2] - The company anticipates further losses in the first half of 2025, with expected net profit ranging from -27 million to -35 million yuan [2][3] Group 3 - In response to operational challenges, the company is attempting digital upgrades and marketing network development to enhance competitiveness, though the effectiveness of these measures remains uncertain [3]

Core Viewpoint - The company plans to issue shares to specific investors, primarily its controlling shareholder, Fuhua Chemical, to raise funds for various projects and enhance its capital structure [4][5][9]. Group 1: Share Issuance Details - The company intends to issue up to 181,338,685 shares, which will not exceed 30% of the total share capital after excluding treasury shares [5]. - The issuance price is set at 6.31 yuan per share, which is at least 80% of the average trading price over the previous 20 trading days [4]. - The total amount to be raised from this issuance is capped at 1,144.2471 million yuan [6]. Group 2: Use of Proceeds - The funds raised will be allocated to specific projects, with the total investment amounting to 1,144.2471 million yuan [6]. - If the net proceeds are insufficient for project needs, the company will use its own funds or other financing methods to cover the shortfall [6]. Group 3: Shareholder Meeting Agenda - The shareholder meeting will include discussions on the feasibility analysis report for the fund usage, the dilution of immediate returns, and measures to compensate for this dilution [9][10][11]. - The meeting will also address the authorization for the board to handle all matters related to the share issuance [12][13]. Group 4: Regulatory Compliance - The company has confirmed its eligibility to issue shares to specific investors under relevant laws and regulations [2][4]. - The issuance will comply with the requirements set forth by the China Securities Regulatory Commission and the Shanghai Stock Exchange [4][12]. Group 5: Related Transactions - The share issuance constitutes a related party transaction as Fuhua Chemical is the controlling shareholder [11]. - Fuhua Chemical has committed to not transferring the newly issued shares for 36 months post-issuance [14].